These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 29912702)
1. Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification. Bougard D; Bélondrade M; Mayran C; Bruyère-Ostells L; Lehmann S; Fournier-Wirth C; Knight RS; Will RG; Green AJE Emerg Infect Dis; 2018 Jul; 24(7):1364-1366. PubMed ID: 29912702 [TBL] [Abstract][Full Text] [Related]
2. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent. Bélondrade M; Nicot S; Mayran C; Bruyere-Ostells L; Almela F; Di Bari MA; Levavasseur E; Watts JC; Fournier-Wirth C; Lehmann S; Haïk S; Nonno R; Bougard D Sci Rep; 2021 Feb; 11(1):4058. PubMed ID: 33603091 [TBL] [Abstract][Full Text] [Related]
3. Prion protein amplification techniques. Green AJE; Zanusso G Handb Clin Neurol; 2018; 153():357-370. PubMed ID: 29887145 [TBL] [Abstract][Full Text] [Related]
4. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification. Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132 [TBL] [Abstract][Full Text] [Related]
5. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
6. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification. Camacho MV; Telling G; Kong Q; Gambetti P; Notari S Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376 [TBL] [Abstract][Full Text] [Related]
7. V180I genetic Creutzfeldt-Jakob disease: Severe degeneration of the inferior olivary nucleus in an autopsied patient with identification of the M2T prion strain. Watanabe M; Nakamura K; Saito R; Takeuchi A; Takahashi T; Kitamoto T; Onodera O; Kakita A Neuropathology; 2023 Dec; 43(6):479-485. PubMed ID: 37165430 [TBL] [Abstract][Full Text] [Related]
8. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531 [TBL] [Abstract][Full Text] [Related]
9. No Adaptation of the Prion Strain in a Heterozygous Case of Variant Creutzfeldt-Jakob Disease. Boyle A; Plinston C; Laing F; Mackenzie G; Will RG; Manson JC; Diack AB Emerg Infect Dis; 2020 Jun; 26(6):1300-1303. PubMed ID: 32441626 [TBL] [Abstract][Full Text] [Related]
10. Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes. Diack AB; Boyle A; Plinston C; Hunt E; Bishop MT; Will RG; Manson JC Brain; 2019 May; 142(5):1416-1428. PubMed ID: 30938429 [TBL] [Abstract][Full Text] [Related]
11. Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid. Barria MA; Lee A; Green AJ; Knight R; Head MW J Pathol Clin Res; 2018 Apr; 4(2):86-92. PubMed ID: 29665324 [TBL] [Abstract][Full Text] [Related]
12. A case of MV2K subtype of sporadic Creutzfeldt-Jakob disease with florid-like plaques: Similarities and differences to variant Creutzfeldt-Jakob disease. Bošnjak M; Zupan A; Fiorini M; Popović KŠ; Popović M Neuropathology; 2020 Aug; 40(4):389-398. PubMed ID: 32249464 [TBL] [Abstract][Full Text] [Related]
13. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
14. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Mitrová E; Belay G Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632 [TBL] [Abstract][Full Text] [Related]
15. Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies. Bélondrade M; Jas-Duval C; Nicot S; Bruyère-Ostells L; Mayran C; Herzog L; Reine F; Torres JM; Fournier-Wirth C; Béringue V; Lehmann S; Bougard D mSphere; 2020 Jan; 5(1):. PubMed ID: 31996421 [TBL] [Abstract][Full Text] [Related]
18. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565 [TBL] [Abstract][Full Text] [Related]
19. PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. Bishop MT; Pennington C; Heath CA; Will RG; Knight RS BMC Med Genet; 2009 Dec; 10():146. PubMed ID: 20035629 [TBL] [Abstract][Full Text] [Related]
20. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Wadsworth JD; Asante EA; Desbruslais M; Linehan JM; Joiner S; Gowland I; Welch J; Stone L; Lloyd SE; Hill AF; Brandner S; Collinge J Science; 2004 Dec; 306(5702):1793-6. PubMed ID: 15539564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]